U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07628777) titled 'Fecal Microbiota Transplantation for Elderly Patients With HFpEF: A Randomized Controlled Trial' on May 24.
Brief Summary: This is a single-center, randomized, double-blind, placebo-controlled trial designed to evaluate the efficacy and safety of fecal microbiota transplantation (FMT) in elderly patients with heart failure with preserved ejection fraction (HFpEF).
HFpEF is a common type of heart failure in older adults, often associated with poor quality of life and frequent hospitalizations. Recent research suggests that changes in gut bacteria may contribute to the progression of HFpEF. FMT aims to restore a healthy gut microbiome...